Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

U.S. patent for antithrombotic agents issued to Burnham Institute

Sep. 10, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

RPR discloses new factor Xa inhibitors

Sep. 10, 1997

Promising phase II results for Genzyme Transgenics' rhATIII

Sep. 9, 1997

Novastan granted priority review status by FDA

Sep. 9, 1997

T-686 inhibits thrombus formation without hemostatic impairment

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

DuPont Merck discloses new anticoagulants

Sep. 4, 1997

Reteplase is superior to alteplase in pulmonary embolism

Sep. 2, 1997

New inhibitors of platelet aggregation from Taiwan

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.